reviewTop 1% cited
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
The Lancet · 2013 · Vol. 383(9921) · pp. 955–962
Christian T. Ruff✉(Brigham and Women's Hospital)Robert P. Giugliano(Brigham and Women's Hospital)Eugene Braunwald(Brigham and Women's Hospital)Elaine Hoffman(Brigham and Women's Hospital)Naveen Deenadayalu(Brigham and Women's Hospital)Michael D. Ezekowitz(Jefferson College)A. John Camm(St George's, University of London)Jeffrey I. Weitz(McMaster University)Basil S. Lewis(Carmel Medical Center)Alexander ParkhomenkoTakeshi Yamashita(Cardiovascular Institute Hospital)Elliott M. Antman(Harvard University)
Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementVenous Thromboembolism Diagnosis and ManagementMedicineAtrial fibrillationWarfarinStroke (engine)Internal medicineMyocardial infarctionRandomized controlled trialRelative riskTIMIMeta-analysis
MeSH terms
Administration, OralAnticoagulantsAtrial FibrillationEmbolismHumansWarfarinRandomized Controlled Trials as TopicTreatment OutcomeStroke
Citations
4,908
FWCI
175.74
field-weighted impact
References
45
Percentile
100%
vs. same field & year
Citations per year
Cited by
2021 ESC/EACTS Guidelines for the management of valvular heart disease
European Heart Journal · 2021 · 5,236 citations
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
European Heart Journal · 2018 · 2,120 citations
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Kidney International · 2024 · 6,803 citations
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
Stroke · 2021 · 2,829 citations
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
Thrombosis and Haemostasis · 2021 · 469 citations
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
European Heart Journal · 2016 · 11,387 citations
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
Circulation · 2019 · 2,707 citations
Antithrombotic Therapy for Atrial Fibrillation
CHEST Journal · 2018 · 924 citations
References
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
Annals of Internal Medicine · 2007 · 4,775 citations
Validation of Clinical Classification Schemes for Predicting Stroke
JAMA · 2001 · 4,834 citations
Stroke and thromboembolism in atrial fibrillation: A systematic review of stroke risk factors, risk stratification schema and cost effectiveness data
Thrombosis and Haemostasis · 2008 · 369 citations
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
New England Journal of Medicine · 2011 · 9,320 citations
Measuring inconsistency in meta-analyses
BMJ · 2003 · 61,700 citations
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
CHEST Journal · 2010 · 4,410 citations
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
New England Journal of Medicine · 2009 · 11,130 citations
Apixaban versus Warfarin in Patients with Atrial Fibrillation
New England Journal of Medicine · 2011 · 8,827 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.